Literature DB >> 3023324

Metabolism and analysis of cysteinyl leukotrienes in the monkey.

C Denzlinger, A Guhlmann, P H Scheuber, D Wilker, D K Hammer, D Keppler.   

Abstract

Predominant hepatobiliary elimination from blood and subsequent enterohepatic circulation of cysteinyl leukotrienes is demonstrated in the monkey Macaca fascicularis. From intravenous [3H]leukotriene C4, about 40% were recovered as metabolites in bile and about 20% in urine within 5 h. [3H]Leukotriene E4 was a predominant metabolite of defined structure in blood plasma, bile, and urine. From intraduodenal [3H]leukotriene C4, about 5% were recovered as metabolites in bile and about 8% in urine within 8 h. Endogenous cysteinyl leukotrienes generated in vivo were measured after implantation of a subcutaneously looped biliary bypass. Tapping of the loop allowed access to bile and prevented interference by leukotrienes produced by surgical trauma (Denzlinger, C., Rapp, S., Hagmann, W., and Keppler, D. (1985) Science 230, 330-332). Endogenous cysteinyl leukotrienes were analyzed in bile, urine, and blood plasma by the sequential use of high-performance liquid chromatography and a radioimmunoassay that was optimized for leukotriene E4 as a predominant metabolite detected in the tracer studies. Biliary leukotriene E4 rose from less than 0.2 to 9 nmol/liter, when leukotriene synthesis was elicited in anesthesized monkeys by staphylococcal enterotoxin B administered intragastrically. This study provides an approach to the analysis of cysteinyl leukotrienes in primates and serves to define the role of these mediators under pathophysiological as well as physiological conditions in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023324

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.

Authors:  M N Samhoun; D M Conroy; P J Piper
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

2.  Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster.

Authors:  H A Lehr; A Guhlmann; D Nolte; D Keppler; K Messmer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies.

Authors:  B Reck; P H Scheuber; W Londong; B Sailer-Kramer; K Bartsch; D K Hammer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 4.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

5.  Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice.

Authors:  G M Habib; Z Z Shi; A A Cuevas; Q Guo; M M Matzuk; M W Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Endogenous leukotriene D4 formation during anaphylactic shock in the guinea pig.

Authors:  A Keppler; L Orning; K Bernström; S Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary disease.

Authors:  Nicolas de Prost; Claudine El-Karak; Maria Avila; Fumito Ichinose; Marcos F Vidal Melo
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03-05       Impact factor: 5.209

8.  Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats.

Authors:  P Liu; N Kawada; Y Mizoguchi; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1992-10

9.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.

Authors:  C Denzlinger; M Grimberg; A Kapp; C Haberl; W Wilmanns
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.